Complications of COVID-19 Pneumonia and Multiple Sclerosis Exacerbation
Prashanth J Jaisankar1, Aurelia Kucera1, Christine M Lomiguen1,2
1Department of Medical Education, Lake Erie College of Osteopathic Medicine, Erie, USA.
Abstract:
Multiple sclerosis (MS) is the most common autoimmune disease in the United States, in which demyelination of the brain and spinal cord disrupts the transmission of signals throughout the body. With an average life expectancy of 30 years from the start of the disease, treatment relies on symptom management through steroids and disease-modifying agents, as there is no cure. While MS patients have not been shown to be at increased risk for coronavirus disease 19 (COVID-19) infection, prolonged hospitalizations and severe COVID-19 sequelae have been linked to various MS subgroups. Limited studies, however, have reported on the role of COVID-19 in precipitating MS exacerbations, as flare-ups often occur during times of stress or immunological insult. Here we present a 45-year-old patient with relapsing-remitting multiple sclerosis whose neurological symptoms worsened sharply in the weeks following an inpatient admission for COVID-19 pneumonia.
Insights
Multiple sclerosis (MS) patients may experience worsening neurological symptoms after contracting coronavirus disease 19 (COVID-19). This case highlights a potential link between severe COVID-19 and MS exacerbations, even without increased infection risk.
Area of Science:
- Neuroimmunology
- Infectious Diseases
Background:
- Multiple sclerosis (MS) is a chronic autoimmune disease affecting the central nervous system.
- Current treatments focus on symptom management as there is no cure for MS.
Observation:
- MS patients are not at higher risk for COVID-19 infection.
- Severe COVID-19 and prolonged hospitalizations have been linked to certain MS subgroups.
- Limited research exists on COVID-19 triggering MS relapses.
Findings:
- A 45-year-old patient with relapsing-remitting MS experienced a significant worsening of neurological symptoms post-COVID-19 pneumonia hospitalization.
- This exacerbation occurred in the weeks following the COVID-19 illness.
Implications:
- COVID-19 may act as an immunological insult, potentially precipitating MS exacerbations.
- Further research is needed to understand the relationship between COVID-19 and MS disease activity.
- This case underscores the importance of monitoring MS patients during and after infectious illnesses like COVID-19.
More Related Videos
Related Concept Videos
01:30Pneumonia III: Complications and Assessment
01:29Pneumonia II: Pathophysiology
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
01:30Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
01:28Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
01:20COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...